Wordt geladen...
Imatinib Enhances Functional Outcome after Spinal Cord Injury
We investigated whether imatinib (Gleevec®, Novartis), a tyrosine kinase inhibitor, could improve functional outcome in experimental spinal cord injury. Rats subjected to contusion spinal cord injury were treated orally with imatinib for 5 days beginning 30 minutes after injury. We found that imatin...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3378614/ https://ncbi.nlm.nih.gov/pubmed/22723886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0038760 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|